4554

Fuji Pharma Co.,Ltd.

富士製薬工業株式会社
Pharmaceutical
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
← Companies
Price
¥2,339
Market Cap
¥57.3B
Ent. Value
¥75.6B
Net Debt
−¥18.3B
Shares Out.
24.5M
P / E
19.0×
EV / EBIT
15.1×
P / Book
1.22×
P / NCAV
40.43×
Div. Yield
1.95%
Financials
Metric FY 2025
EDINET ↗ 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥51.7B ¥46.1B ¥40.9B ¥35.4B ¥34.0B
Cost of Sales ¥30.9B ¥28.3B ¥24.4B ¥20.9B ¥19.2B
Gross Profit ¥20.8B ¥17.8B ¥16.5B ¥14.6B ¥14.8B
SG&A ¥15.8B ¥14.0B ¥12.7B ¥10.8B ¥11.4B
Operating Income ¥5.0B ¥3.9B ¥3.9B ¥3.8B ¥3.3B
Non-Operating Income ¥187M ¥812M ¥790M ¥330M ¥30M
Dividend Income — — ¥77M ¥43M ¥7M
Non-Operating Expenses ¥718M ¥247M ¥129M ¥382M ¥129M
Interest Expense ¥330M ¥196M ¥107M ¥77M ¥53M
Ordinary Income ¥4.5B ¥4.4B ¥4.5B ¥3.7B ¥3.2B
Pre-tax Income ¥4.0B ¥8.3B ¥4.4B ¥3.7B ¥3.4B
Income Taxes ¥1.0B ¥2.1B ¥963M ¥1.0B ¥938M
Current Tax ¥1.3B ¥2.1B ¥1.0B ¥1.2B ¥1.3B
Deferred Tax ¥-608M ¥18M ¥-38M ¥-144M ¥-326M
Net Income (owners) ¥3.0B ¥6.1B ¥3.4B ¥2.7B ¥2.4B
Minority Interest ¥0M ¥0M ¥0M ¥0M ¥0M
Comprehensive Income ¥2.2B ¥5.3B ¥6.3B ¥3.9B ¥2.9B
EBITDA ¥9.0B ¥7.6B ¥6.9B ¥6.5B ¥5.5B
Goodwill Amort. (J-GAAP) ¥90M ¥337M ¥316M ¥283M ¥278M
EPS ¥122.94 ¥252.85 ¥141.37 ¥111.01 ¥90.54
Shares Outstanding 24.5M 24.4M 24.3M 24.3M 24.3M
Shares Issued (total) 24.9M 24.8M 24.8M 24.8M 24.8M
Treasury Shares 0.4M 0.4M 0.4M 0.4M 0.4M